CVC Funds has acquired Sunday Natural, a leading European producer of vitamins and supplements, for $983 million. The deal closed on April 1, 2024.

Deal-at-a-Glance
Acquirer:CVC Funds (DE)
Target:Sunday Natural (DE)
Value:$983m
Type:Buyout
Date Closed:April 1, 2024
Advisors (Buy-side):CVC Capital Partners, Houlihan Lokey, BC Partners
Advisors (Sell-side):Houlihan Lokey
Legal Advisors (Buy-side):Rothschild, Simpson Thacher & Bartlett, Skadden
Legal Advisors (Sell-side):Not Disclosed

The acquisition aims to support Sunday Natural’s growth and international expansion. CVC Funds plans to leverage its investment expertise to scale the company's operations, enhance product offerings, and enter new markets.

Deal Mechanics

CVC Funds acquired Sunday Natural in a deal valued at $983 million, closing on April 1, 2024. The acquisition was facilitated by buy-side advisors CVC Capital Partners, Houlihan Lokey, and BC Partners. Sell-side advice came from Houlihan Lokey.

Legal counsel for the buyer included Rothschild, Simpson Thacher & Bartlett, and Skadden. Legal representation for Sunday Natural is not publicly disclosed.

Strategic Rationale

The rationale behind this deal revolves around CVC Funds' desire to enhance Sunday Natural's market presence and product portfolio through strategic investments. By supporting the company’s international growth plans, CVC aims to capitalize on the rising demand for natural health supplements.

Financial Context

Sunday Natural has been rapidly expanding its operations across Europe with a focus on vitamin D and other essential vitamins. The acquisition by CVC Funds will provide the necessary financial support and strategic guidance required for further scaling up in both existing markets and new geographies.